In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9500659
APP PUB NO 20140295469A1
SERIAL NO

14232405

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An immunoassay for the quantification of fragments having an N- or a C-terminal neo-epitope formed by cleavage of a titin protein by a proteinase is provided. The immunoassay includes the steps of contacting a sample with an antibody specifically binding to the N- or C-terminal neo-epitope of the fragments and determining the level of binding.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NORDIC BIOSCIENCE A/S2730 HERLEV

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Karsdal, Morten Copenhagen, DK 45 50
Leeming, Diana Julie Espergaerde, DK 9 6
Vassiliadis, Efstathios Rodovre, DK 6 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 22, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00